426 related articles for article (PubMed ID: 16918062)
21. Assessing the antifungal activity, pharmacokinetics, and tissue distribution of amphotericin B following the administration of Abelcet and AmBisome in combination with caspofungin to rats infected with Aspergillus fumigatus.
Wasan KM; Sivak O; Rosland M; Risovic V; Bartlett K
J Pharm Sci; 2007 Jul; 96(7):1737-47. PubMed ID: 17080414
[TBL] [Abstract][Full Text] [Related]
22. Safety of caspofungin for treating invasive nasal sinus aspergillosis in a kidney transplant recipient.
Said T; Nampoory MR; Nair MP; Al-Saleh M; Al-Haj KH; Halim MA; Johny KV; Samhan M; Al-Mousawi M
Transplant Proc; 2005 Sep; 37(7):3038-40. PubMed ID: 16213297
[TBL] [Abstract][Full Text] [Related]
23. Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis.
Wagner D; Sander A; Bertz H; Finke J; Kern WV
Infection; 2005 Oct; 33(5-6):397-400. PubMed ID: 16258877
[TBL] [Abstract][Full Text] [Related]
24. A cost-effectiveness analysis of caspofungin vs. liposomal amphotericin B for treatment of suspected fungal infections in the UK.
Bruynesteyn K; Gant V; McKenzie C; Pagliuca T; Poynton C; Kumar RN; Jansen JP
Eur J Haematol; 2007 Jun; 78(6):532-9. PubMed ID: 17419744
[TBL] [Abstract][Full Text] [Related]
25. Differences in efficacy and cytokine profiles following echinocandin or liposomal amphotericin B monotherapy or combination therapy for murine pulmonary or systemic Aspergillus flavus infections.
Olson JA; Schwartz J; Hahka D; George A; Proffitt RT; Adler-Moore JP
Antimicrob Agents Chemother; 2012 Jan; 56(1):218-30. PubMed ID: 21968353
[TBL] [Abstract][Full Text] [Related]
26. A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole.
Forestier E; Remy V; Lesens O; Martinot M; Hansman Y; Eisenmann B; Christmann D
Eur J Clin Microbiol Infect Dis; 2005 May; 24(5):347-9. PubMed ID: 15889298
[TBL] [Abstract][Full Text] [Related]
27. [Successful treatment with caspofungin of an invasive candidosis resistant to liposomal amphotericin B in a neutropenic patient].
Rome A; André N; Michel A; Coze C; Gentet JC; Bernard JL
Arch Pediatr; 2006 Dec; 13(12):1556-7. PubMed ID: 17049216
[No Abstract] [Full Text] [Related]
28. [Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy].
Ozçelik T; Ozkalemkaş F; Kocaeli H; Altundal Y; Ener B; Ali R; Ozkocaman V; Hakyemez B; Tunali A
Mikrobiyol Bul; 2009 Jul; 43(3):499-506. PubMed ID: 19795628
[TBL] [Abstract][Full Text] [Related]
29. Successful management of cerebral and pulmonary mucormycosis with liposomal amphotericin B in a 28-year-old woman with acute lymphoblastic leukemia.
Salonen JH
Acta Biomed; 2006; 77 Suppl 2():28-31. PubMed ID: 16918065
[TBL] [Abstract][Full Text] [Related]
30. Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant.
Castagnola E; Machetti M; Cappelli B; Molinari AC; Morreale G; Dodero P; Tomà P; Faraci M
Clin Microbiol Infect; 2004 Mar; 10(3):255-7. PubMed ID: 15008948
[TBL] [Abstract][Full Text] [Related]
31. Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections.
Nivoix Y; Zamfir A; Lutun P; Kara F; Remy V; Lioure B; Rigolot JC; Entz-Werlé N; Letscher-Bru V; Waller J; Levêque D; Koffel JC; Beretz L; Herbrecht R
J Infect; 2006 Jan; 52(1):67-74. PubMed ID: 16368463
[TBL] [Abstract][Full Text] [Related]
32. Successful antifungal combination therapy with voriconazole and caspofungin.
Schuster F; Moelter C; Schmid I; Graubner UB; Kammer B; Belohradsky BH; Führer M
Pediatr Blood Cancer; 2005 Jun; 44(7):682-5. PubMed ID: 15700260
[TBL] [Abstract][Full Text] [Related]
33. Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate.
Goodman D; Pamer E; Jakubowski A; Morris C; Sepkowitz K
Clin Infect Dis; 2002 Aug; 35(3):E35-6. PubMed ID: 12115115
[TBL] [Abstract][Full Text] [Related]
34. Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B.
Bassetti M; Bisio F; Di Biagio A; Pierri I; Balocco M; Soro O; Cruciani M; Bassetti D
J Antimicrob Chemother; 2004 Aug; 54(2):575-7. PubMed ID: 15231763
[No Abstract] [Full Text] [Related]
35. Caspofungin and liposomal amphotericin B therapy of experimental murine scedosporiosis.
Bocanegra R; Najvar LK; Hernandez S; McCarthy DI; Graybill JR
Antimicrob Agents Chemother; 2005 Dec; 49(12):5139-41. PubMed ID: 16304187
[TBL] [Abstract][Full Text] [Related]
36. An open study of the comparative efficacy and safety of caspofungin and liposomal amphotericin B in treating invasive fungal infections or febrile neutropenia in patients with haematological malignancy.
Ellis M; Frampton C; Joseph J; Alizadeh H; Kristensen J; Hauggaard A; Shammas F
J Med Microbiol; 2006 Oct; 55(Pt 10):1357-1365. PubMed ID: 17005784
[TBL] [Abstract][Full Text] [Related]
37. A case of pulmonary aspergillosis with lack of response to caspofungin.
Rüchel R; Perske C; Glass B; Bäsecke J
Rev Iberoam Micol; 2006 Jun; 23(2):94-6. PubMed ID: 16854185
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of disseminated aspergillosis with the combination of voriconazole, caspofungin, granulocyte transfusions, and surgery followed by allogeneic blood stem cell transplantation in a patient with primary failure of an autologous stem cell graft.
Dinser R; Grgic A; Kim YJ; Pfreundschuh M; Schubert J
Eur J Haematol; 2005 May; 74(5):438-41. PubMed ID: 15813919
[TBL] [Abstract][Full Text] [Related]
39. Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.
Ament AJ; Hübben MW; Verweij PE; de Groot R; Warris A; Donnelly JP; van 't Wout J; Severens JL
J Antimicrob Chemother; 2007 Aug; 60(2):385-93. PubMed ID: 17561501
[TBL] [Abstract][Full Text] [Related]
40. Caspofungin versus liposomal amphotericin B for empirical therapy.
Kontoyiannis DP; Lewis RE
N Engl J Med; 2005 Jan; 352(4):410-4; author reply 410-4. PubMed ID: 15673808
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]